SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.13-0.5%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (6454)6/14/1998 10:18:00 PM
From: aknahow  Read Replies (3) of 17367
 
From the Bio Conference site in XOMAs own word a description of the type of partnership they are looking for for Neuprex and indeed I-PREX and Mycoprex. If one takes it at face value they are looking for marketing/sales collaboration agreements!!! This fits with what XOMA has said in the past. May explain the delaying getting agreements, in that the partner will not be able to claim the lions share for having sponsored the development and trials.

Any thoughts on this??

"XOMA is primarily seeking a commercialization
partner for Neuprex(tm). The company is seeking separate product
commercialization partnerships I-PREX(tm) and Mycoprex(tm). XOMA
also has several technologies available for .........."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext